In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development

• Main Authors: Goto, Masahiro (Author), Piper Hanley, Karen Piper (Author), Marcos, Josep (Author), Wood, Peter J. (Author), Wright, Sarah (Author), Postle, Anthony D. (Author), Cameron, Iain T. (Author), Mason, J. Ian (Author), Wilson, David I. (Author), Hanley, Neil A. (Author)
• Format: Article
• Language: English
• Published: 2006-04-03.
• Subjects: Article
• Online Access: Get fulltext

 In humans, sexual differentiation of the external genitalia is established at 7-12 weeks post conception (wpc). During this period, maintaining the appropriate intrauterine hormone environment is critical. In contrast to other species, this regulation extends to the human fetal adrenal cortex, as evidenced by the virilization that is associated with various forms of congenital adrenal hyperplasia. The mechanism underlying these clinical findings has remained elusive. Here we show that the human fetal adrenal cortex synthesized cortisol much earlier than previously documented, an effect associated with transient expression of the orphan nuclear receptor nerve growth factor IB-like (NGFI-B) and its regulatory target, the steroidogenic enzyme type 2 3ß-hydroxysteroid dehydrogenase (HSD3B2). This cortisol biosynthesis was maximal at 8-9 wpc under the regulation of ACTH. Negative feedback was apparent at the anterior pituitary corticotrophs. ACTH also stimulated the adrenal gland to secrete androstenedione and testosterone. In concert, these data promote a distinctive mechanism for normal human development whereby cortisol production, determined by transient NGFI-B and HSD3B2 expression, provides feedback at the anterior pituitary to modulate androgen biosynthesis and safeguard normal female sexual differentiation.